Pulmonary Aspergilloma: A Treatment Challenge in Sub-Saharan Africa

PLoS Neglected Tropical Diseases

Volumn 7, Issue 10, 2013, Pages

  Pohl, Christian ^a,b,c   Jugheli, Levan ^a,b,c   Haraka, Fredrick ^a   Mfinanga, Elirehema ^a   Said, Khadija ^a   Reither, Klaus ^a,b,c  

^a IFAKARA HEALTH INSTITUTE   (Tanzania)

^b SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

^c UNIVERSITY OF BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; ISONIAZID; ITRACONAZOLE; PYRAZINAMIDE; RIFAMPICIN;

AGED; ARTICLE; ASPERGILLOMA; BODY MASS; CASE REPORT; COUGHING; DIFFERENTIAL DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FOLLOW UP; HUMAN; MALE; MYCOBACTERIUM TUBERCULOSIS; NIGHT SWEAT; NUCLEIC ACID AMPLIFICATION; PREVALENCE; THORAX PAIN; THORAX RADIOGRAPHY; TUBERCULOSIS;

AFRICA SOUTH OF THE SAHARA; AGED; ANTIFUNGAL AGENTS; ASPERGILLUS; HUMANS; MALE; MYCETOMA; PULMONARY ASPERGILLOSIS; RADIOGRAPHY, THORACIC; THORACIC SURGERY;

EID: 84887273182     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0002352     Document Type: Article

References (15)

1. Kousha M, Tadi R, Soubani A, (2011) Pulmonary aspergillosis: a clinical review. Eur Respir Rev 20: 156-174 doi:10.1183/09059180.00001011.
2. Kawamura S, Maesaki S, Tomono K, Tashiro T, Kohno S, (2000) Clinical evaluation of 61 patients with pulmonary aspergilloma. Internal Med 39: 209-212.
3. Soubani AO, Chandrasekar PH, (2002) The clinical spectrum of pulmonary aspergillosis. Chest 121: 1988-1999.
4. Thompson BH, Stanford W, Galvin JR, Kurihara Y, (1995) Varied radiologic appearances of pulmonary aspergillosis. Radiographics 15: 1273-1284.
5. Hammerman KJ, Christianson CS, Huntington I, Hurst GA, Zelman M, et al. (1973) Spontaneous lysis of aspergillomata. Chest 64: 697-699.
6. Regnard JF, Icard P, Nicolosi M, Spagiarri L, Magdeleinat P, et al. (2000) Aspergilloma: a series of 89 surgical cases. Ann Thorac Surg 69: 898-903.
7. Kauffman CA, (1996) Quandary about treatment of aspergillomas persists. Lancet 347: 1640.
8. Lee JG, Lee CY, Park IK, Kim DJ, Chang J, et al. (2009) Pulmonary aspergilloma: analysis of prognosis in relation to symptoms and treatment. J Thorac Cardiovasc Surg 138: 820-825 doi:10.1016/j.jtcvs.2009.01.019.
9. Walsh TJ, Anaissie EJ, Denning DW, Herbrecht R, Kontoyiannis DP, et al. (2008) Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 46: 327-360 doi:10.1086/525258.
10. Campbell JH, Winter JH, Richardson MD, Shankland GS, Banham SW, (1991) Treatment of pulmonary aspergilloma with itraconazole. Thorax 46: 839-841.
11. Grysczyk H, De Roux A, Grassot A, Mauch H, Lode H, (2002) [Antimycotic treatment of pulmonary aspergilloma in patients without neutropenia]. Dtsch Med Wochenschr 127: 492-496 doi:10.1055/s-2002-20940.
12. Dupont B, (1990) Itraconazole therapy in aspergillosis: study in 49 patients. J Am Acad Dermatol 23: 607-614.
13. Baciewicz AM, Chrisman CR, Finch CK, Self TH, (2008) Update on rifampin and rifabutin drug interactions. Am J Med Sci 335: 126-136 doi:10.1097/MAJ.0b013e31814a586a.
14. Ministry of Health and Social Welfare (2006) Manual of the National Tuberculosis and Leprosy Programme in Tanzania. 5th edition. United Republic of Tanzania.
15. Hopewell PC, Pai M, Maher D, Uplekar M, Raviglione MC, (2006) International standards for tuberculosis care. Lancet Infect Dis 6: 710-725 doi:10.1016/S1473-3099(06)70628-4.